According to the report, the ASRs and RUOs market in the U.S. was valued at US$ 3.6 Bn in 2020 and is projected to expand at CAGR of 4.7% from 2021 to 2031.
Albany NY, United States: U.S. ASRs and RUOs Market: Introduction
According to the report, the ASRs and RUOs market in the U.S. was valued at US$ 3.6 Bn in 2020 and is projected to expand at CAGR of 4.7% from 2021 to 2031. Research use only (RUO) means an in vitro diagnostic product that is in the laboratory research phase of development and is being shipped or delivered for an investigation. Certain products, such as instruments, systems, and reagents, are considered under for research use only products segment.
These products are used to carry out research and are not the object of the research. These include products intended for use in discovering and developing medical knowledge related to human disease and conditions. For instance, instruments and reagents intended for use in research attempting to isolate a gene linked with a particular disease could be labeled for research use only when such instruments and reagents are not intended to produce results for clinical use.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84310
Increase in Use of ASRs in Diagnostic Applications: Key Driver
Analyte specific reagents (ASRs) are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents, which through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens.
The FDA's insistence that ASRs, such as genomic microarrays used for clinical applications, constitute in vitro diagnostics, and therefore fall under a different regulatory rubric, has far-reaching implications for developers of technologies such as microchips.
Get COVID-19 Analysis on ASRs and RUOs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84310
Increase in usage of ASRs in diagnostic testing helps healthcare providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care. Rise in use of ASRs in various diagnostic applications are expected to boost the growth of the ASRs and RUOs market in the U.S. during the forecast period.
Human Healthcare Segment to Lead U.S. ASRs and RUOs Market
The human healthcare segment dominated the market in 2020. The segment is projected to register high market attractiveness index by 2031. The segment is anticipated to expand at high CAGR from 2021 to 2031. The segment’s dominance is attributed to increase in use of ASRs and RUOs in specific disease diagnosis, new product development, and increase in research & development activities.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84310
Competition Landscape
Key players operating in the ASRs and RUOs market in U.S. include BioLegend, Inc., ELITechGroup, BD, bioMerieux, Inc., Genetic Signatures, Thermo Fisher Scientific, Inc., Danaher Corporation, DiaSorin Molecular LLC, LGC Biosearch Technologies, altona Diagnostics GmbH, and QIAGEN.
Browse more Reports by Transparency Market Research:
Elderly and Disabled Assistive Devices Market: The rising geriatric population across the globe is a major factor contributing to the elderly and disabled assistive devices market growth. The increasing geriatric population is more likely to prone to physical disabilities, hearing issues, vision loss, etc.
Continuous Glucose Monitoring Market: Increase in incidence of diabetes globally and rise in awareness about CGM devices that have the ability to detect hyperglycemic and hypoglycemic events in real time are expected to fuel the growth of the global market during the forecast period.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/